c-MET anticorps (pTyr1356)
Aperçu rapide pour c-MET anticorps (pTyr1356) (ABIN3028834)
Antigène
Voir toutes c-MET (MET) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr1356
-
Fonction
- Phospho-MET Antibody (pY1356)
-
Purification
- Antigen affinity
-
Immunogène
- This phospho-MET antibody was produced from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding pY1356 of human MET.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the phospho-MET antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the phospho-MET antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- c-MET (MET) (Met Proto-Oncogene (MET))
-
Autre désignation
- MET
-
Sujet
- The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma.
-
UniProt
- P08581
-
Pathways
- Signalisation RTK, Carbohydrate Homeostasis, Synaptic Membrane, Signaling of Hepatocyte Growth Factor Receptor
Antigène
-